Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

NICE set to knock-back Amgen's myeloma treatment Kyprolis

NICE set to knock-back Amgen's myeloma treatment Kyprolis NICE's draft guidance is part of its assessment for NHS use of Kyprolis (carflizomib) in combination with Celgene's Revlimid (lenalidomide) and dexamethasone to treat adults who have received at ... NICE's draft guidance on its use in combination with

Celgene bolsters blood cancer portfolio with $600m EngMab buy

Celgene bolsters blood cancer portfolio with $600m EngMab buy bb2121 started phase I testing earlier this year. EngMab consolidates Celgene's position as the top company in the multiple myeloma market at the moment, thanks to blockbuster drugs Revlimid (lenalidomide)

Celgene disappointed as Revlimid fails lymphoma trial

Celgene disappointed as Revlimid fails lymphoma trial PFS alone is not considered compelling as Revlimid carries a risk of serious side effects, including thrombosis. ... It is important to note that Celgene is not abandoning Revlimid as a DLBCL therapy just yet.

Celgene’s Revlimid cleared for aggressive lymphoma type in EU

Celgene’s Revlimid cleared for aggressive lymphoma type in EU The European Commission has approved Celgene's Revlimid for a new indication that for the first time expands the drug's use beyond multiple myeloma in the EU. ... The new labeling means that Revlimid (lenalidomide) can now be used to treat adults with

Amgen's Kyprolis wins new indication in Europe

Amgen's Kyprolis wins new indication in Europe Last November it was approved in Europe in combination with Celgene's Revlimid (lenalidomide) as well as dexamethasone in this therapy area, after receiving the green light in the US more

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...
2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....

Infographics